Author/Authors :
Javidnia, Katayoun Medicinal & Natural Products Chemistry Research Centre, Shiraz University of The Medical Sciences, Shiraz , Miria, Ramin Medicinal & Natural Products Chemistry Research Centre, Shiraz University of The Medical Sciences, Shiraz , Movahed, Ladan Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz , Golrangi, Shohreh Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz
Abstract :
Nifedipine (NIF) a 1, 4-dihydropyridine calcium channel antagonist, undergoes
photodegradation to nitroso analogues of dehydronifedipine (NDNIF) when exposed to sunlight.
Photodegradation products of NIF have no clinical activity, so different formulations of NIF
must remain unchanged. If NIF preparations become unstable in exposure to light, they could
cause therapeutic failure. The present study was carried out in order to investigate the
photostability of commercially available NIF products, in Iran. Three oral NIF formulations
available in Iran were studied using indirect sunlight (daylight) and continuous artificial light
exposure extending over a period of 12 weeks. The extent of photodecomposition of NIF was
determined using a specific reversed phase high performance liquid chromatography (HPLC)
method. NIF photodegradation was measured using both pure NIF powder as well as a
methanolic NIF solution to determine differences in the effectiveness of artificial light and
natural indirect sunlight sources used in this study. All the tested NIF formulations were likely to
be photostable up to at least 12 weeks of continuous artificial and natural day light exposure,
compared with pure NIF powder and methanolic solution. Photodegradation of NIF powder and
methanolic solution exposed to indirect sunlight was faster than the artificial light
Keywords :
Nifedipine , Photostability , HPLC , Daylight , Artificial light